Cooper Companies Inc (NYSE:COO) Shares Sold by Russell Investments Group Ltd.

Share on StockTwits

Russell Investments Group Ltd. reduced its position in Cooper Companies Inc (NYSE:COO) by 49.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,779 shares of the medical device company’s stock after selling 12,564 shares during the period. Russell Investments Group Ltd.’s holdings in Cooper Companies were worth $4,264,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Allianz Asset Management GmbH raised its position in Cooper Companies by 3.4% during the second quarter. Allianz Asset Management GmbH now owns 303,394 shares of the medical device company’s stock worth $102,211,000 after acquiring an additional 9,947 shares during the period. Commerzbank Aktiengesellschaft FI raised its position in Cooper Companies by 74.3% during the second quarter. Commerzbank Aktiengesellschaft FI now owns 3,523 shares of the medical device company’s stock worth $1,187,000 after acquiring an additional 1,502 shares during the period. JPMorgan Chase & Co. raised its position in Cooper Companies by 37.2% during the second quarter. JPMorgan Chase & Co. now owns 88,137 shares of the medical device company’s stock worth $29,222,000 after acquiring an additional 23,892 shares during the period. Swiss National Bank raised its position in Cooper Companies by 2.7% during the first quarter. Swiss National Bank now owns 214,000 shares of the medical device company’s stock worth $63,380,000 after acquiring an additional 5,700 shares during the period. Finally, Wealthfront Advisers LLC raised its position in Cooper Companies by 31.2% during the first quarter. Wealthfront Advisers LLC now owns 1,536 shares of the medical device company’s stock worth $455,000 after acquiring an additional 365 shares during the period. Hedge funds and other institutional investors own 96.00% of the company’s stock.

Shares of Cooper Companies stock traded down $3.49 during trading hours on Friday, reaching $301.51. 381,934 shares of the company’s stock were exchanged, compared to its average volume of 346,629. Cooper Companies Inc has a 1 year low of $228.65 and a 1 year high of $344.32. The company has a market capitalization of $15.12 billion, a P/E ratio of 26.22, a price-to-earnings-growth ratio of 2.30 and a beta of 0.93. The business has a fifty day moving average of $324.81 and a two-hundred day moving average of $309.03. The company has a quick ratio of 0.73, a current ratio of 1.29 and a debt-to-equity ratio of 0.39.

Cooper Companies (NYSE:COO) last released its earnings results on Thursday, August 29th. The medical device company reported $3.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.16 by $0.07. Cooper Companies had a net margin of 17.08% and a return on equity of 17.15%. The business had revenue of $679.40 million during the quarter, compared to analyst estimates of $687.60 million. During the same quarter in the prior year, the firm earned $3.00 earnings per share. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. As a group, research analysts predict that Cooper Companies Inc will post 12.32 EPS for the current year.

In related news, VP Randal Golden sold 1,154 shares of the company’s stock in a transaction dated Wednesday, June 19th. The shares were sold at an average price of $328.16, for a total value of $378,696.64. Following the completion of the sale, the vice president now owns 1,148 shares of the company’s stock, valued at $376,727.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gary S. Petersmeyer sold 355 shares of the company’s stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $323.92, for a total transaction of $114,991.60. The disclosure for this sale can be found here. Insiders sold 11,376 shares of company stock valued at $3,685,676 in the last three months. 1.70% of the stock is currently owned by insiders.

COO has been the subject of a number of research analyst reports. KeyCorp set a $351.00 price objective on shares of Cooper Companies and gave the stock a “buy” rating in a research report on Friday, August 30th. Piper Jaffray Companies set a $360.00 price objective on shares of Cooper Companies and gave the stock a “buy” rating in a research report on Friday, August 30th. ValuEngine cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Tuesday, September 10th. Wells Fargo & Co upped their price objective on shares of Cooper Companies from $356.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Finally, Raymond James reaffirmed a “buy” rating on shares of Cooper Companies in a report on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $326.27.

Cooper Companies Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Further Reading: What is dividend yield?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.